EventsEventsPodcasts
Loader

Find Us

In 2023, the WHO approved the Kenya-based Universal Corporation Limited to produce a crucial antimalarial drug known as sulfadoxine-pyrimethamine plus amodiaquineq.

Video. Could a new locally produced drug help Kenya overcome deadly malaria?

The WHO approved a Kenya-based pharma company to produce a crucial antimalarial drug locally, reducing reliance on imports from India and China.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT